Strain-Specific expression of spliced MMTV RNAs containing the superantigen gene

Virology

Volumn 236, Issue 1, 1997, Pages 54-65

  Xu, Li ^a   Wrona, Thomas J ^a   Dudley, Jaquelin P ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; LONG TERMINAL REPEAT; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; STRAIN DIFFERENCE; VIRUS INFECTION; VIRUS STRAIN;

ANIMALIA; EXOGENOUS MOUSE MAMMARY TUMOR VIRUS; MAMMARY TUMOR ONCOVIRUS; MAMMARY TUMOR VIRUS; MOUSE MAMMARY TUMOR VIRUS; MOUSE MAMMARY TUMOR VIRUS 17; ONCOVIRINAE; TUMOR VIRUS;

EID: 0031572230     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8717     Document Type: Article

References (49)

1. Acha-Orbea, H., Shakhov, A. N., Scarpellino, L., Kolb, E., Muller, V., Vessaz-Shaw, A., Fuchs, R., Blochlinger, K., Rollini, P., Billote, J., Sarafidou, M., MacDonald, H. R., and Diggelmann, H. (1991). Clonal deletion of Vβ14-bearing T cells in mice transgenic for mammary tumour virus. Nature 350, 207-211.
2. Alberts, B., Bray, D., Lewis, J., Raff, M., Roberts, K., and Watson, J. D., Eds. (1994) "Molecular Biology of the Cell," 3rd ed. Garland, New York.
3. Beutner, U., Frankel, W. N., Cote, M. S., Coffin, J. M., and Huber, B. T. (1992). MIs-1 is encoded by the long terminal repeat open reading frame of the mouse mammary tumor provirus Mtv-7. Proc. Natl. Acad. Sci. USA 89, 5432-5436.
4. Beutner, U., Kraus, E., Kitamura, D., Rajewsky, K., and Huber, B. T. (1994). B cells are essential for murine mammary tumor virus transmission, but not for presentation of endogenous superantigens. J. Exp. Med. 179, 1457-1466.
5. Brandt-Carlson, C., Butel, J. S., and Wheeler, D. (1993). Phylogenetic and structural analyses of MMTV LTR ORF sequences of exogenous and endogenous origins. Virology 193, 171-185.
6. Brown, T. (1993). Analysis of RNA by Northern and slot blot hybridization. In "Current Protocols in Molecular Biology" (F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl, Eds.), Vol. 1, pp. 4.9.1-4.9.8. Wiley, New York.
7. Campbell, M., Renshaw-Gegg, L., Renne, R., and Luciw, P. A. (1994). Characterization of the internal promoter of simian foamy viruses. J. Virol. 68, 4811-4820.
8. Cho, K., Ferrick, D. A., and Morris, D. W. (1995). Structure and biological activity of the subgenomic Mtv-6 endogenous provirus. Virology 206, 395-402.
9. Elliott, J. F., Pohajdak, B., Talbot, D. J., Shaw, J., and Paetkau, V. (1988). Phorbol diester-inducible, cyclosporine-suppressible transcription from a novel promoter within the mouse mammary tumor virus env gene. J. Virol. 62, 1373-1380.
10. Frohman, M. A., Dush, M. K., and Martin, G. R. (1988). Rapid production of full-length cDNAs from rare transcripts: Amplification using a single gene-specific oligonucleotide primer. Proc. Natl. Acad. Sci. USA 85, 8998-9002.
11. Golovkina, T. V., Chervonsky, A., Dudley, J. P., and Ross, S. R. (1992). Transgenic mouse mammary tumor virus superantigen expression prevents viral infection. Cell 69, 637-645.
12. Golovkina, T. V., Chervonsky, A., Prescott, J. A., Janeway, C. A., Jr., and Ross, S. R. (1994). The mouse mammary tumor virus envelope gene product is required for superantigen presentation to T cells. J Exp. Med. 179, 439-446.
13. Gunzburg, W. H., Heinemann, F., Wintersperger, S., Miethke, T., Wagner, H., Erfle, V., and Salmons, B. (1993). Endogenous superantigen expression controlled by a novel promoter in the MMTV long terminal repeat. Nature 364, 154-158.
14. Held, W. H., Acha-Orbea, H., MacDonald, H. R., and Waanders, G. A. (1994). Superantigens and retroviral infection: Insights from mouse mammary tumor virus. Immunol. Today 15, 184-190.
15. Henrard, D., and Ross, S. R. (1988). Endogenous mouse mammary tumor virus is expressed in several organs in addition to the lactating mammary gland. J. Virol. 62, 3046-3049.
16. Hilgers, J., and Bentvelzen, P. (1978). Interaction between viral and genetic factors in murine mammary cancer. Adv. Cancer Res. 26, 143-195.
17. Horowitz, D. S., and Krainer, A. R. (1994). Mechanisms for selecting 5′ splice sites in mammalian pre-mRNA splicing. Trends Genet. 10, 100-106.
18. Janeway, C. A. (1991 ). MIs: Makes a little sense. Nature 349, 459-461.
19. Jarvis, C. D., Germain, R. N., Hager, G. L., Damschroder, M., and Matis, L. A. (1994). Tissue-specific expression of messenger RNAs encoding endogenous viral superantigens. J. Immunol. 152, 1032-1038.
20. Karapetian, Q., Shakhov, A. N., Kraehenbuhl, J.-P., and Acha-Orbea, H. (1994). Retroviral infection of neonatal Peyer's patch lymphocytes: The mouse mammary tumor virus model. J. Exp. Med. 180, 1511-1516.
21. Kennedy, N., Knedlitschek, G., Groner, B., Hynes, N. E., Herrlich, P., Michalides, R., and van Ooyen, A. J. J. (1982). Long terminal repeats of endogenous mouse mammary tumour virus contain a long open reading frame which extends into adjacent sequences. Nature 295, 622-624.
22. Kim, K. J., Kanellopoulos-Langevin, C., Merwin, R. M., Sachs, D. H., and Asofsky, R. (1979). Establishment and characterization of BALB/c lymphoma lines with B cell properties. J. Immunol. 122, 549-554.
23. Klement, V., Rowe, W. P., Hartley, J. W., and Pugh, W. E. (1969). Mixed culture cytopathogenicity: A new test for growth of murine leukemia viruses in tissue culture. Proc. Natl. Acad. Sci. USA 63, 753-758.
24. Kozak, M. (1986). Bifunctional messenger RNAs in eukaryotes. Cell 47, 481-483.
25. Lochelt, M., Muranyi, W., and Flugel, R. M. (1993). Human foamy virus genome possesses an internal, Bel-1-dependent and functional promoter. Proc. Natl. Acad. Sci. USA 90, 7317-7321.
26. Majors, J. E., and Varmus, H. E. (1983). Nucleotide sequencing of an apparent proviral copy of env mRNA defines determinants of expression of the mouse mammary tumor virus env gene. J. Virol. 47, 495-504.
27. Miller, C. L., Garner, R., and Paetkau, V. (1992). An activation-dependent, T-lymphocyte-specific transcriptional activator in the mouse mammary tumor virus env gene. Mol. Cell. Biol. 12, 3262-3272.
28. Mohan, N., Mottershead, D., Subramanyam, M., Beutner, U., and Huber, B. T. (1993). Production and characterization of an MIs-1-specific monoclonal antibody. J. Exp. Med. 177, 351-358.
29. Moore, R, Dixon, M., Smith, R., Peters, G., and Dickson, C. (1987). Complete nucleotide sequence of a milk-transmitted mouse mammary tumor virus: Two frameshift suppression events are required for translation of gag and pol. J. Virol. 61, 480-490.
30. Morley, K. L., Toohey, M. G., and Peterson, D. O. (1987). Transcriptional repression of a hormone-responsive promoter. Nucleic Acids Res. 15, 6973-6989.
31. Mudgett-Hunter, M., Anderson, W., Haber, E., and Margolies, M. N. (1985). Binding and structural diversity among high-affinity monoclonal anti-digoxin antibodies. Mol. Immunol. 22, 477-488.
32. Nicolas, J.-F., Wegmann, D., Lebrun, P., Kaiserlian, D., Tovey, J., and Glasebrook, A. L. (1987). Relationship of B cell Fc receptors to T cell recognition of MIs antigen. Eur. J. Immunol. 17, 1561-1565.
33. Owens, R. B., and Hackett, A. J. (1972). Tissue culture studies of mouse mammary tumor cells and associated viruses. J. Natl. Cancer Inst. 49, 1321-1332.
34. Palmiter, R. D. (1974). Magnesium precipitation of ribonucleoprotein complexes. Expedient techniques for the isolation of undegraded polysomes and messenger ribonucleic acid. Biochemistry 13, 3606-3615.
35. Peters, G., and Dickson, C. (1987) On the mechanism of carcinogenesis by mouse mammary tumor virus. In "Cellular and Molecular Biology of Breast Cancer" (D. Medina, W. Kidwell, G. Heppner, and E. Anderson, Eds.), pp. 307-319. Plenum, New York.
36. Reuss, F. U., and Coffin, J. M. (1995). Stimulation of mouse mammary tumor virus superantigen expression by an intragenic enhancer. Proc. Natl. Acad. Sci. USA 92, 9293-9297.
37. Ringold, G. M., Cardiff, R. D., Varmus, H. E., and Yamamoto, K. R. (1977). Infection of cultured rat hepatoma cells by mouse mammary tumor virus. Cell 10, 11-18.
38. Ross, S. R., Hsu, C. L., Choi, Y., Mok, E., and Dudley, J. P. (1990). Negative regulation in correct tissue-specific expression of mouse mammary tumor virus in transgenic mice. Mol. Cell. Biol. 10, 5822-5829.
39. Salmons, B., Knedlitschek, G., Kennedy, N., Groner, B., and Ponta, H. (1986). The endogenous mouse mammary tumour virus locus Mtv-8 contains a defective envelope gene. Virus Res. 4, 377-389.
40. Sambasivarao, D., and Paetkau, V. (1996). Interactions of a transcriptional activator in the env gene of the mouse mammary tumor virus with activation-dependent, T cell-specific transacting factors. J. Biol. Chem. 271, 8942-8950.
41. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) "Molecular Cloning: a Laboratory Manual," 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
42. Shackleford, G. M., and Varmus, H. E. (1988). Construction of a clonable, infectious, and tumorigenic mouse mammary tumor virus provirus and a derivative genetic vector. Proc. Natl. Acad. Sci. USA 85, 9655-9659.
43. Southern, P. J., and Berg, P. (1982). Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. J. Mol. Appl. Genet. 1, 327-341.
44. van Ooyen, A. J., Michalides, R. J., and Nusse, R. (1983). Structural analysis of a 1.7-kilobase mouse mammary tumor virus-specific RNA. J. Virol. 46, 362-370.
45. Wheeler, D. A., Butel, J. S., Medina, D., Cardiff, R. D., and Hager, G. L. (1983). Transcription of mouse mammary tumor virus: Identification of a candidate mRNA for the long terminal repeat gene product. J. Virol. 46, 42-49.
46. Wrona, T., and Dudley, J. P. (1996). Major histocompatibility complex class II I-E-independent transmission of C3H mouse mammary tumor virus. J. Virol. 70, 1246-1249.
47. Xu, L., Wrona, T. J., and Dudley, J. P. (1996). Exogenous mouse mammary tumor virus (MMTV) infection induces endogenous MMTV sag expression. Virology 215, 113-123.
48. Yang, J. N., and Dudley, J. (1992). Endogenous Mtv-8 or a closely linked sequence stimulates rearrangement of the downstream Vκ9 gene. J. Immunol. 149, 1242-1251.
49. Zhang, D.-J., Tsiagbe, V. K., Huang, C., and Thorbecke, G. J. (1996). Control of endogenous mouse mammary tumor virus superantigen expression in SJL lymphomas by a promoter within the env region. J. Immunol. 157, 3510-3517.